Ballentine Partners’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $59.2K | Buy |
11,743
+968
| +9% | +$4.88K | ﹤0.01% | 959 |
|
|
2025
Q1 | $69.8K | Sell |
10,775
-159
| -1% | -$1.03K | ﹤0.01% | 871 |
|
|
2024
Q4 | $80.3K | Sell |
10,934
-442
| -4% | -$3.24K | ﹤0.01% | 853 |
|
|
2024
Q3 | $85.2K | Sell |
11,376
-1,143
| -9% | -$8.56K | ﹤0.01% | 812 |
|
|
2024
Q2 | $111K | Sell |
12,519
-1,185
| -9% | -$10.5K | ﹤0.01% | 722 |
|
|
2024
Q1 | $139K | Buy |
13,704
+1,160
| +9% | +$11.8K | ﹤0.01% | 698 |
|
|
2023
Q4 | $126K | Buy |
12,544
+1,915
| +18% | +$19.3K | ﹤0.01% | 651 |
|
|
2023
Q3 | $99.6K | Buy |
+10,629
| New | +$99.6K | ﹤0.01% | 578 |
|